Awareness and Practice of Renal Dose Adjustment Guidelines among Doctors: A Survey-Based Study

Authors

  • Dr. Krithika Sri Clinical Pharmacologist, Gleneagles Hospital, Chennai, Tamil Nadu, India Author
  • Barath Raj R C. I Baid Metha College of Pharmacy, Tamil Nadu, India Author
  • Anjali J Pharm D Intern, Erode College of Pharmacy, Erode, Tamil Nadu, India Author
  • Berlin Suji Pharm D Intern, Erode College of Pharmacy, Erode, Tamil Nadu, India Author
  • Sraddha R Pharm D Intern, SCS College of Pharmacy, Harapanahalli, Karnataka, India Author
  • Sandra Joemol Koshy Pharm D Intern, SCS College of Pharmacy, Harapanahalli, Karnataka, India Author
  • Sneha Charmika Pharm D Intern, SCS College of Pharmacy, Harapanahalli, Karnataka, India Author

Keywords:

Renal impairment, Dose adjustment, eGFR, Drug safety, Healthcare awareness

Abstract

Background: Renal dose adjustment is vital for patient safety, particularly in those with impaired kidney function. This study assesses doctors’ awareness, practices, and perceived barriers across specialties. Objective: This study assesses doctors' awareness and practices related to renal dose adjustment using a structured questionnaire-based analysis. Methods: A cross-sectional survey of 40 doctors from various departments gathered data on clinical experience, renal dosing practices, references used, and perceived responsibilities and barriers. Results: Among the 40 respondents, over 80% recognized the importance of renal dose adjustment, and about 70% routinely considered eGFR or creatinine clearance. More than 75% agreed that all renally excreted drugs should be adjusted, yet only 30% had received formal training or CME. The most cited barrier was a lack of updated knowledge. Lexicomp and Medscape were the preferred references. While most used renal dosing in emergencies, nearly half limited it to specific drugs. Conclusion: Doctors show moderate awareness of renal dose adjustment, but knowledge gaps and limited training remain key barriers. Improving education, involving clinical pharmacists, and encouraging use of trusted references can enhance safe prescribing in renal impairment.

Downloads

Download data is not yet available.

References

Bustingorry MA, Beratarrechea A, Soria A, Bendersky M, Rubistein A. Inappropriate drug dosing in patients with renal impairment in the hospital setting: a cross-sectional study. Int J Clin Pharm. 2020;42(3):763–72.

Salman M, Khan AH, Adnan AS, Bukhari NI, Hassali MA. Knowledge and practices of physicians regarding renal dose adjustment of drugs: A cross-sectional study. PLoS One. 2021;16(3):e0247893.

KDIGO CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150.

Alahmari AA, Asiri YA, Alanazi AS, Aljadhey HS, Alshahrani SM. Evaluation of physicians’ knowledge about medication dosage adjustment in patients with chronic kidney disease. Saudi Pharm J. 2020;28(6):652–6.

American College of Clinical Pharmacy. Drug dosing adjustments in patients with renal impairment. Pharmacotherapy. 2020;40(10):934–51.

Fink JC, Christenson RH. Estimating renal function for drug dosing decisions. Clin J Am Soc Nephrol. 2017;12(10):1615–7.

Delanaye P, Glassock RJ, Pottel H, Eckardt KU. An overview of CKD: Definition, epidemiology, and classification. Kidney Int Suppl. 2017;7(1):19–21.

Downloads

Published

20-09-2025

Issue

Section

Research Articles

How to Cite

Awareness and Practice of Renal Dose Adjustment Guidelines among Doctors: A Survey-Based Study. (2025). International Journal of Scientific Research in Science and Technology, 12(5), 113-117. https://mail.ijsrst.com/index.php/home/article/view/IJSRST25125107